Midatech achieves positive dosing data for OpsiSporin Uveitis programme
21. April 2016 02:00 ET
|
Midatech Pharma PLC
ABINGDON, England, April 21, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH) (Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing products...
Midatech Pharma PLC (“Midatech” or the “Company”) Audited financial results for the year ended 31 December 2015
13. April 2016 02:00 ET
|
Midatech Pharma PLC
Midatech will host a conference call and live Q&A session today (Wednesday 13 April 2016) at 1300 BST / 0800 EDT for analysts and investors to discuss the Annual Results. Dr Jim Phillips, Chief...
Midatech’s Commercial Launch of Zuplenz® (Ondansetron) Oral Soluble Film to Prevent Post-Operative, Chemotherapy and Radiation-Induced Nausea and Vomiting in US
11. April 2016 02:00 ET
|
Midatech Pharma PLC
ABINGDON, England, April 11, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH); (Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing...
Midatech Pharma Recognises International Rare Disease Day 2016
29. Februar 2016 02:00 ET
|
Midatech Pharma PLC
ABINGDON, Va., Feb. 29, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH), (Nasdaq:MTP), the international specialty pharmaceutical company focused on developing and commercialising products in...
Midatech Pharma to Present at Biotech Showcase™ 2016
07. Januar 2016 16:00 ET
|
Midatech Pharma PLC
OXFORD, United Kingdom, Jan. 07, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH) (Nasdaq:MTP), the international specialty pharmaceutical company focused on developing and commercialising...
Midatech Pharma PLC (“Midatech”, the “Company” or the “Group”) Pre-Close Trading Update
06. Januar 2016 02:00 ET
|
Midatech Pharma PLC
OXFORD, United Kingdom, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and commercialising...
Midatech Signs Licensing Agreement With Emergex Vaccines
04. Januar 2016 02:00 ET
|
Midatech Pharma PLC
CAMBRIDGE, United Kingdom, Jan. 04, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH) (Nasdaq:MTP), the international specialty pharmaceutical company focused on developing and commercialising...
Midatech Completes Acquisition of Zuplenz®
30. Dezember 2015 02:00 ET
|
Midatech Pharma PLC
OXFORDSHIRE, United Kingdom, Dec. 30, 2015 (GLOBE NEWSWIRE) -- Midatech Pharma (“Midatech” or the “Company” or the “Group”) (AIM:MTPH) (Nasdaq:MTP), the international specialty pharmaceutical...
Midatech Pharma PLC Director Dealing
18. Dezember 2015 08:56 ET
|
Midatech Pharma PLC
OXFORDSHIRE, United Kingdom, Dec. 18, 2015 (GLOBE NEWSWIRE) -- Midatech (AIM:MTPH), the international specialty pharmaceutical company focused on developing and commercialising products in...
Midatech Agrees to Acquire Marketed Oncology Product, Zuplenz®, From Galena Biopharma, Inc.
18. Dezember 2015 02:00 ET
|
Midatech Pharma PLC
OXFORDSHIRE, United Kingdom, Dec. 18, 2015 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH), the international specialty pharmaceutical company focused on developing and commercialising products in...